Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

HIV and AIDS: looking ahead

Nature Medicine volume 9, pages 887–891 (2003)Cite this article

Although the future of HIV science is uncertain, we need to reappraise HIV diversity, pathogenesis and immunity. The AIDS pandemic threatens the success of existing vaccine programs and may accelerate the emergence of new infectious diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The human toll of AIDS.

Katie Ris

Figure 2: The scale of HIV variation.

Katie Ris

References

  1. Weiss, R.A. Gulliver's travels in HIVland. Nature 410, 963–967 (2001).

    Article  CAS  PubMed  Google Scholar 

  2. Fields, B.N. AIDS: time to turn to basic science. Nature 369, 95–96 (1994).

    Article  CAS  PubMed  Google Scholar 

  3. Barré-Sinoussi, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868–871 (1983).

    Article  PubMed  Google Scholar 

  4. Vilmer, E. et al. Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet 1, 753–757 (1984).

    Article  CAS  PubMed  Google Scholar 

  5. Ellrodt, A. et al. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet 1, 1383–1385 (1984).

    Article  CAS  PubMed  Google Scholar 

  6. Montagnier, L. et al. A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: structural and antigenic relatedness with equine infectious anaemia virus. Ann. Virol. 135E, 119–134 (1984).

    Google Scholar 

  7. Wain Hobson, S., Sonigo, P., Danos, O., Cole, S. & Alizon, M. Nucleotide sequence of the AIDS virus, LAV. Cell 40, 9–17 (1985).

    Article  CAS  PubMed  Google Scholar 

  8. Gallo, R.C. et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500–503 (1984).

    Article  CAS  PubMed  Google Scholar 

  9. Levy, J.A. et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225, 840–842 (1984).

    Article  CAS  PubMed  Google Scholar 

  10. Fauci, S.A. HIV and AIDS: 20 years of science. Nat. Med. 9, 839–843 (2003)

    Article  CAS  PubMed  Google Scholar 

  11. Stevenson, M. HIV-1 pathogenesis. Nat. Med. 9, 853–860 (2003)

    Article  CAS  PubMed  Google Scholar 

  12. Pomerantz, R.J. & Horn, D.L. 20 years of therapy for HIV-1 infection. Nat. Med. 9, 867–873 (2003)

    Article  CAS  PubMed  Google Scholar 

  13. Serwadda, D. et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 2, 849–852 (1985).

    Article  CAS  PubMed  Google Scholar 

  14. Buvé, A. et al. Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS 15 (suppl. 4), S5–S14 (2001).

    Article  PubMed  Google Scholar 

  15. Gisselquist, D., Potterat, J.J., Brody, S. & Vachon, F. Let it be sexual: how health care transmission of AIDS in Africa was ignored. Int. J. STD AIDS 14, 148–161 (2003).

    Article  PubMed  Google Scholar 

  16. Drucker, E., Alcabes, P.G. & Marx, P.A. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet 358, 1989–1992 (2001).

    Article  CAS  PubMed  Google Scholar 

  17. Joint United Nations Programme on HIV/AIDS (UNAIDS). Expert group stresses that unsafe sex is primary mode of HIV transmission in Africa (UNAIDS, Geneva, 2003).

  18. Walker, P.R., Worobey, M., Rambaut, A., Holmes, E.C. & Pybus, O.G. Epidemiology: sexual transmission of HIV in Africa. Nature 422, 679 (2003).

    Article  CAS  PubMed  Google Scholar 

  19. Valdiserri, R.O., Ogden, L.L. & McCray, E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat. Med. 9, 881–886 (2003)

    Article  CAS  PubMed  Google Scholar 

  20. Weiss, H.A., Quigley, M.A. & Hayes, R.J. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 14, 2361–2370 (2000).

    Article  CAS  PubMed  Google Scholar 

  21. Joint United Nations Programme on HIV/AIDS (UNAIDS). Male circumcision: current epidemiological and field evidence (UNAIDS, Geneva, 2003).

  22. Pope, M. & Haase, A.T. HIV-1 transmission, acute infection, and the quest for strategies to prevent infection. Nat. Med. 9, 847–852 (2003)

    Article  CAS  PubMed  Google Scholar 

  23. Igakura, T. et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cyto-skeleton. Science 299, 1713–1716 (2003).

    Article  CAS  PubMed  Google Scholar 

  24. Jung, A. et al. Multiply infected spleen cells in HIV patients. Nature 418, 144 (2002).

    Article  CAS  PubMed  Google Scholar 

  25. Cowan, S. et al. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99, 11914–11919 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hatziioannou, T., Cowan, S., Goff, S.P., Bieniasz, P.D. & Towers, G.J. Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J. 22, 385–394 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Reeves, J.D. & Doms, R.W. Human immunodeficiency virus type 2. J. Gen. Virol. 83, 1253–1265 (2002).

    Article  CAS  PubMed  Google Scholar 

  28. Sigurdsson, B., Thormar, H. & Palsson, P.A. Cultivation of visna virus in tissue culture. Arch. Virusforschung 10, 430–443 (1960).

    Google Scholar 

  29. Weiss, R.A. Lentivirus tropism and pathogenesis. Immunol. Lett. 66, 3–5 (1999).

    Article  CAS  PubMed  Google Scholar 

  30. Sala, M. & Wain-Hobson, S. Are RNA viruses adapting or merely changing? J. Mol. Evol. 51, 12–20 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Korber, B. et al. Evolutionary and immunological implications of contemporary HIV-1 variation. Brit. Med. Bull. 58, 19–42 (2001).

    Article  CAS  PubMed  Google Scholar 

  32. Perelson, A.S. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2, 28–36 (2002).

    Article  CAS  PubMed  Google Scholar 

  33. Korber, B. et al. Timing the ancestor of the HIV-1 pandemic strains. Science 288, 1789–1796 (2000).

    Article  CAS  PubMed  Google Scholar 

  34. Lemey, P. et al. Tracing the origin and history of the HIV-2 epidemic. Proc. Natl. Acad. Sci. USA 100, 6588–6592 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Hahn, B.H., Shaw, G.M., De Cock, K.M. & Sharp, P.M. AIDS as a zoonosis: scientific and public health implications. Science 287, 607–614 (2000).

    Article  CAS  PubMed  Google Scholar 

  36. Takehisa, J. et al. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J. Virol. 73, 6810–6820 (1999).

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Kaye, J.F. & Lever, A.M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72, 5877–5885 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. McMichael, A.J. & Hanke, T. HIV vaccines 1983–2003. Nat. Med. 9, 874–880 (2003)

    Article  CAS  PubMed  Google Scholar 

  39. Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307–312 (2003).

    Article  CAS  PubMed  Google Scholar 

  40. Richman, D.D., Wrin, T., Little, S.J. & Petropoulos, C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100, 4144–4149 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650 (2002).

    Article  CAS  PubMed  Google Scholar 

  42. O'Brien, S.J. & Moore, J.P. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol. Rev. 177, 99–111 (2000).

    Article  CAS  PubMed  Google Scholar 

  43. Gonzalez, E. et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proc. Natl. Acad. Sci. USA 98, 5199–5204 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. French, N. et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355, 2106–2111 (2000).

    Article  CAS  PubMed  Google Scholar 

  45. Subramaniam, K.S., Segal, R., Lyles, R.H., Rodriguez-Barradas, M.C. & Pirofski, L.A. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. J. Infect. Dis. 187, 758–768 (2003).

    Article  CAS  PubMed  Google Scholar 

  46. Moss, J.W., Clements, C.J. & Halsey, N.A. Immunization of children at risk of infection with human immunodeficiency virus. Bull. World Health Organ. 81, 61–70 (2003).

    PubMed  PubMed Central  Google Scholar 

  47. Bartlett, J.G. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. Clin. Infect. Dis. 36, 468–471 (2003).

    Article  PubMed  Google Scholar 

  48. Redfield, R.R. et al. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 316, 673–676 (1987).

    Article  CAS  PubMed  Google Scholar 

  49. Boshoff, C. & Weiss, R.A. AIDS-related malignancies. Nat. Rev. Cancer 2, 373–382 (2002).

    Article  CAS  PubMed  Google Scholar 

  50. Wald, A. & Link, K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185, 45–52 (2002).

    Article  PubMed  Google Scholar 

  51. Mbopi-Keou, F.X. et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J. Infect. Dis. 182, 1090–1096 (2000).

    Article  CAS  PubMed  Google Scholar 

  52. Tillmann, H.L. et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med. 345, 715–724 (2001).

    Article  CAS  PubMed  Google Scholar 

  53. Xiang, J. et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N. Engl. J. Med. 345, 707–714 (2001).

    Article  CAS  PubMed  Google Scholar 

  54. Watt, G. et al. HIV-1 suppression during acute scrub-typhus infection. Lancet 356, 475–479 (2000).

    Article  CAS  PubMed  Google Scholar 

  55. Watt, G., Kantipong, P. & Jongsakul, K. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin. Infect. Dis. 36, 1067–1069 (2003).

    Article  PubMed  Google Scholar 

  56. Walsh, P.D. et al. Catastrophic ape decline in western equatorial Africa. Nature 422, 611–614 (2003).

    Article  CAS  PubMed  Google Scholar 

  57. Nabel, G.J. Vaccine for AIDS and Ebola virus infection. Virus Res. 93, 213–217 (2003).

    Article  Google Scholar 

  58. Weiss, R.A. HIV and AIDS in relation to other pandemics. EMBO Rep. 4, 510–514 (2003).

    Article  Google Scholar 

Download references

Acknowledgements

I thank A. Fassati, B. Korber, Á. McKnight, G. Towers and H. Weiss for critical comments. My research on HIV is supported by the Medical Research Council.

Author information

Authors and Affiliations

  1. Department of Immunology & Molecular Pathology, University College London, 46 Cleveland Street, London, W1T 4JF, UK

    Robin A Weiss

Authors
  1. Robin A Weiss
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, R. HIV and AIDS: looking ahead. Nat Med 9, 887–891 (2003). https://doi.org/10.1038/nm0703-887

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nm0703-887

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing